INTRATHECAL CHEMOTHERAPY FOR CANCERAMOTOSIS OF THE BRAIN MININGS.

Authors

  • Khusanov Zafar Toshmurodovich
  • Aliev Mansur Abdukholikovich.
  • Kholmurodova Khulkar Kholiyorovna

Keywords:

To improve treatment outcomes and quality of life of breast cancer patients with carcinomatosis of the meninges of the brain and spinal cord.

Abstract

Previously, carcinomatosis of the meninges of the brain and spinal cord was considered
a rare manifestation of metastatic disease. However, leptomeningeal disease is now becoming
increasingly evident as many drugs do not reach sufficient concentrations in the cerebrospinal fluid to
act on tumor cells, and the number of patients is increasing due to increasing life expectancy with
modern treatment [1–3]. Carcinomatosis of the meninges of the brain or spinal cord is an unfavorable
factor and is associated with a poor prognosis

Downloads

Published

2024-08-15

How to Cite

Toshmurodovich, K. Z., Abdukholikovich. , A. M., & Khulkar Kholiyorovna, K. (2024). INTRATHECAL CHEMOTHERAPY FOR CANCERAMOTOSIS OF THE BRAIN MININGS. American Journal of Pediatric Medicine and Health Sciences (2993-2149), 2(8), 81–83. Retrieved from http://grnjournal.us/index.php/AJPMHS/article/view/5658

Issue

Vol. 2 No. 8 (2024): American Journal of Pediatric Medicine and Health Sciences

Section

Articles